[Clinical evaluation of aztreonam in children].

Author: ItoS, MikawaH, MochizukiY, OhkuboH, YoshidaA

Paper Details 
Original Abstract of the Article :
Clinical usage of aztreonam (AZT), a newly synthesized antibiotic which belongs to monobactam, was evaluated for its efficacy and safety in 22 patients aged from 1 month-old to 13 year-5 month-old with bacterial infections and the following results were obtained. AZT was administered to 4 patients w...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/4094060

データ提供:米国国立医学図書館(NLM)

Aztreonam: A Shining Oasis in the Pediatric Desert

The world of pediatric medicine is a delicate landscape, much like a desert where even the smallest changes can have a profound impact. This research explores the efficacy and safety of aztreonam (AZT), a novel antibiotic, in the treatment of bacterial infections in children. The authors, like careful desert guides, navigate the intricacies of AZT's clinical usage, examining its effectiveness against various pathogens and its impact on young patients. Their findings highlight the promising therapeutic potential of AZT, offering hope for children battling bacterial infections.

A Powerful Weapon in the Fight Against Bacterial Infections

This study reveals the impressive efficacy of AZT in treating bacterial infections in children. The authors report a high success rate, with minimal side effects, offering a beacon of hope for young patients facing these challenges.

Navigating Pediatric Care with Caution

While AZT demonstrates significant potential, the study underscores the importance of careful monitoring, just as a desert traveler must be cautious of potential dangers. The authors emphasize the need for vigilant observation and responsible use of AZT to ensure its safety and efficacy in pediatric patients.

Dr.Camel's Conclusion

Aztreonam emerges as a promising therapeutic option for children battling bacterial infections. Like a refreshing oasis in the desert, it offers hope and relief. However, like navigating a delicate desert ecosystem, it's crucial to use AZT responsibly and monitor patients carefully to ensure their safety and well-being.

Date :
  1. Date Completed 1986-04-21
  2. Date Revised 2016-11-16
Further Info :

Pubmed ID

4094060

DOI: Digital Object Identifier

4094060

Related Literature

SNS
PICO Info
in preparation
Languages

Japanese

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.